Inhibition of DNA methylation by caffeic acid and chlorogenic acid, two common catechol-containing coffee polyphenols

被引:269
作者
Lee, WJ [1 ]
Zhu, BT [1 ]
机构
[1] Univ S Carolina, Coll Pharm, Dept Basic Pharmceut Sci, Columbia, SC 29208 USA
关键词
D O I
10.1093/carcin/bgi206
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We studied the modulating effects of caffeic acid and chlorogenic acid (two common coffee polyphenols) on the in vitro methylation of synthetic DNA substrates and also on the methylation status of the promoter region of a representative gene in two human cancer cells lines. Under conditions that were suitable for the in vitro enzymatic methylation of DNA and dietary catechols, we found that the presence of caffeic acid or chlorogenic acid inhibited in a concentration-dependent manner the DNA methylation catalyzed by prokaryotic M.SssI DNA methyltransferase (DNMT) and human DNMT1. The IC50 values of caffeic acid and chlorogenic acid were 3.0 and 0.75 mu M, respectively, for the inhibition of M.SssI DNMT-mediated DNA methylation, and were 2.3 and 0.9 mu M, respectively, for the inhibition of human DNMT1-mediated DNA methylation. The maximal in vitro inhibition of DNA methylation was similar to 80% when the highest concentration (20 mu M) of caffeic acid or chlorogenic acid was tested. Kinetic analyses showed that DNA methylation catalyzed by M.SssI DNMT or human DNMT1 followed the Michaelis-Menten curve patterns. The presence of caffeic acid or chlorogenic acid inhibited DNA methylation predominantly through a non-competitive mechanism, and this inhibition was largely due to the increased formation of S-adenosyl-l-homocysteine (SAH, a potent inhibitor of DNA methylation), resulting from the catechol-O-methyltransferase (COMT)-mediated O-methylation of these dietary catechols. Using cultured MCF-7 and MAD-MB-231 human breast cancer cells, we also demonstrated that treatment of these cells with caffeic acid or chlorogenic acid partially inhibited the methylation of the promoter region of the RAR beta gene. The findings of our present study provide a general mechanistic basis for the notion that a variety of dietary catechols can function as inhibitors of DNA methylation through increased formation of SAH during the COMT-mediated O-methylation of these dietary chemicals.
引用
收藏
页码:269 / 277
页数:9
相关论文
共 37 条
[1]   Phase I trial of continuous infusion 5-aza-2′-deoxycytidine [J].
Aparicio, A ;
Eads, CA ;
Leong, LA ;
Laird, PW ;
Newman, EM ;
Synold, TW ;
Baker, SD ;
Zhao, M ;
Weber, JS .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2003, 51 (03) :231-239
[2]   Recombinant human DNA (cytosine-5) methyltransferase II. Steady-state kinetics reveal allosteric activation by methylated DNA [J].
Bacolla, A ;
Pradhan, S ;
Roberts, RJ ;
Wells, RD .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (46) :33011-33019
[3]   LOSS OF METHYLATION ACTIVATES XIST IN SOMATIC BUT NOT IN EMBRYONIC-CELLS [J].
BEARD, C ;
LI, E ;
JAENISCH, R .
GENES & DEVELOPMENT, 1995, 9 (19) :2325-2334
[4]   CLONING AND SEQUENCING OF A CDNA-ENCODING DNA METHYLTRANSFERASE OF MOUSE CELLS - THE CARBOXYL-TERMINAL DOMAIN OF THE MAMMALIAN ENZYMES IS RELATED TO BACTERIAL RESTRICTION METHYLTRANSFERASES [J].
BESTOR, T ;
LAUDANO, A ;
MATTALIANO, R ;
INGRAM, V .
JOURNAL OF MOLECULAR BIOLOGY, 1988, 203 (04) :971-983
[5]   Antineoplastic action of 5-aza-2′-deoxycytidine and histone deacetylase inhibitor and their effect on the expression of retinoic acid receptor β and estrogen receptor α genes in breast carcinoma cells [J].
Bovenzi, V ;
Momparler, RL .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2001, 48 (01) :71-76
[6]   DNA hypomethylation leads to elevated mutation rates [J].
Chen, RZ ;
Pettersson, U ;
Beard, C ;
Jackson-Grusby, L ;
Jaenisch, R .
NATURE, 1998, 395 (6697) :89-93
[7]   Biological effects of inhibitors of S-adenosylhomocysteine hydrolase [J].
Chiang, PK .
PHARMACOLOGY & THERAPEUTICS, 1998, 77 (02) :115-134
[8]   5-Azacytidine and 5-aza-2′-deoxycytidine as inhibitors of DNA methylation:: mechanistic studies and their implications for cancer therapy [J].
Christman, JK .
ONCOGENE, 2002, 21 (35) :5483-5495
[9]   CpG island hypermethylation and tumor suppressor genes: a booming present, a brighter future [J].
Esteller, M .
ONCOGENE, 2002, 21 (35) :5427-5440
[10]  
Fang MZ, 2003, CANCER RES, V63, P7563